ClinConnect ClinConnect Logo
Search / Trial NCT05619822

A Comprehensive Third-generation Intervention for People With Psychosis and Post-traumatic Stress Symptoms

Launched by UNIVERSIDAD COMPLUTENSE DE MADRID · Nov 10, 2022

Trial Information

Current as of June 27, 2025

Enrolling by invitation

Keywords

Psychosis Trauma Psychological Intervention Emdr

ClinConnect Summary

This study is a randomized clinical trial at psychiatric rehabilitation services of the Public Network of Care for people with serious mental disorders. We hypothesize that participants receiving the intervention, in comparison with controls, will show a reduction in general, PTSD and psychotic symptomatology, an improvement in levels of functioning and well-being, a greater ability to regulate emotions with more help-seeking behaviours.

Given the complexity of both psychosis and PTSD and the reluctance of professionals to treat it, we plan to develop a precise comprehensive protocol. In o...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Those showing a high risk of PTSD (TSQ ≥6) will be further evaluated to determine whether they meet the inclusion criteria. Participants must:
  • Be between the ages of 18 and 65 fluent enough in Spanish language;
  • Meet the criteria for a diagnosis of a psychotic spectrum disorder or a mood disorder with psychotic symptoms according to MINI (Sheeman et al., 1997);
  • Meet PTSD diagnostic criteria according to the Clinician-Administered PTSD Scale (CAPS; Blake et al., 1995)
  • Exclusion Criteria:
  • Those who have a diagnosis of substance or alcohol abuse or dependence in the 30 days prior to participation in the study
  • To have a severe neurocognitive problems or brain damage that interfere with the basic processing of information in psychotherapy.

About Universidad Complutense De Madrid

The Universidad Complutense de Madrid (UCM) is a prestigious academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent sponsor of clinical trials, UCM leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring the highest standards of ethics and scientific rigor in its clinical research initiatives. UCM's dedication to education and research excellence positions it as a leader in the development of new therapeutic interventions and health solutions.

Locations

Pozuelo De Alarcón, Madrid, Spain

Patients applied

0 patients applied

Trial Officials

Carmen Valiente, Ph.D.

Principal Investigator

Universidad Complutense de Madrid

Regina Espinosa, Ph.D.

Principal Investigator

Universidad Camilo Jose Cela

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials